Researchers find link between peptide that switches during stress and depression

September 20, 2012 by Bob Yirka in Neuroscience report

Researchers find link between peptide that switches during stress and depression

Enlarge

Cellular localization of CRF peptide, CRFR1 and CRFR2 in the nucleus accumbens. Credit: (c) Nature (2012) doi:10.1038/nature11436

(Medical Xpress)—Researchers working out of the University of Washington have found that a certain peptide normally involved in helping the brain experience pleasure is caused to switch when subjected to long term stress, leading to depression. The team in trying to understand why long term stress in people quite often leads to debilitating depression, ran some simple experiments in mice that showed, as they describe in their paper published in the journal Nature, that a peptide called corticotropin-releasing factor (CRF), normally involved in helping to release dopamine in a certain part of the brain, causing pleasurable feelings, switches to a non active state leading to symptoms of depression when the mice were exposed to a stress inducing environment.

Scientists have known for some time that long term stress can lead to depression, but not why it happens, though the suspicion has been that it had something to do with the , a section in the brain believed to be involved in feelings of punishment and/or reward. They've also thought that CRF might play a part as it binds to in that part of the brain. To find out what role CRF actually has in the whole process, the researchers set up an experiment to test its impact on .

In the first part of the experiment, the team infused CRF into the brains of one group of mice while another got a shortly after being placed in a new cage. Those that got the CRF, quite naturally, formed a pleasurable attachment to the new cage, while those given a placebo did not. Next, another group of mice were stressed by forcing them to swim in water several times a day for two days (something that previous research has shown causes mice to become depressed) then were subjected to the same experiment as the first two groups. This time, infusing the mice with CRF did not result in the mice forming pleasurable attachments to the new cage, and in some cases caused some to dislike it altogether. Even more alarming was that they kept repeating the cage test over and over periodically and found that it took up to ninety days for the mice to fully recover from the stressful conditions they'd experienced.

The results show, the team says, that CRF is clearly involved when mice, and likely people, are exposed to long term stress and how it can lead to depression. The next logical step then, is to see if there is a way to counteract the impact stress has on CRF, thereby heading off depression.

More information: Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive, Nature (2012) doi:10.1038/nature11436

Abstract
Stressors motivate an array of adaptive responses ranging from 'fight or flight' to an internal urgency signal facilitating long-term goals. However, traumatic or chronic uncontrollable stress promotes the onset of major depressive disorder, in which acute stressors lose their motivational properties and are perceived as insurmountable impediments. Consequently, stress-induced depression is a debilitating human condition characterized by an affective shift from engagement of the environment to withdrawal. An emerging neurobiological substrate of depression and associated pathology is the nucleus accumbens, a region with the capacity to mediate a diverse range of stress responses by interfacing limbic, cognitive and motor circuitry. Here we report that corticotropin-releasing factor (CRF), a neuropeptide released in response to acute stressors and other arousing environmental stimuli, acts in the nucleus accumbens of naive mice to increase dopamine release through coactivation of the receptors CRFR1 and CRFR2. Remarkably, severe-stress exposure completely abolished this effect without recovery for at least 90 days. This loss of CRF's capacity to regulate dopamine release in the nucleus accumbens is accompanied by a switch in the reaction to CRF from appetitive to aversive, indicating a diametric change in the emotional response to acute stressors. Thus, the current findings offer a biological substrate for the switch in affect which is central to stress-induced depressive disorders.

Journal reference: Nature search and more info website

© 2012 Medical Xpress

5 /5 (2 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

Tausch
Sep 20, 2012

Rank: not rated yet
Peptide induced PCT?
http://en.wikiped...ristesse

Are all 'highs' associated with inevitable 'let downs?'
Rank 5 /5 (2 votes)
Relevant PhysicsForums posts

More news stories

For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Neuroscience created May 18, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Neuroscience created May 17, 2013 | popularity 4 / 5 (1) | comments 0 | with audio podcast report

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Neuroscience created May 17, 2013 | popularity 3.7 / 5 (3) | comments 0 | with audio podcast weblog

Deep brain stimulation: A fix when the drugs don't work

Neurological disorders can have a devastating impact on the lives of sufferers and their families.

Neuroscience created May 17, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Brain makes call on which ear is used for cell phone

If you're a left-brain thinker, chances are you use your right hand to hold your cell phone up to your right ear, according to a newly published study from Henry Ford Hospital in Detroit.

Neuroscience created May 16, 2013 | popularity 2 / 5 (2) | comments 0 | with audio podcast


Computational tool translates complex data into simplified 2-dimensional images

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...

New theory on genesis of osteoarthritis comes with successful therapy in mice

Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

Alzheimer's leaves bilingual victims stranded in Canada

The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.

Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...